Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38 alpha MAPK inhibitors.
Bartolini, D., Buhrmann, M., Barreca, M.L., Manfroni, G., Cecchetti, V., Rauh, D., Galli, F.(2019) Biochem Biophys Res Commun 511: 579-586
- PubMed: 30824186 
- DOI: 10.1016/j.bbrc.2019.02.063
- Primary Citation of Related Structures:  
5OMH, 5OMG - PubMed Abstract: 
p38α mitogen-activated protein kinase (MAPK) is an attracting pharmacological target in inflammatory diseases and cancer. Searching for new and more efficient p38-MAPK inhibitors, two recently developed pyrazolobenzothiazine-based (COXP4M12 and COXH11) compounds were investigated in this study using a cellular model of p38 activation ...